- Home
- ARVN vs CCEC Comparison
ARVN vs CCEC Comparison
Compare ARVN & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- CCEC
- Stock Information
- Founded
- ARVN 2015
- CCEC 2007
- Country
- ARVN United States
- CCEC Greece
- Employees
- ARVN N/A
- CCEC N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- CCEC Marine Transportation
- Sector
- ARVN Health Care
- CCEC Consumer Discretionary
- Exchange
- ARVN Nasdaq
- CCEC Nasdaq
- Market Cap
- ARVN 1.2B
- CCEC 1.1B
- IPO Year
- ARVN 2018
- CCEC 2007
- Fundamental
- Price
- ARVN $7.02
- CCEC $19.24
- Analyst Decision
- ARVN Buy
- CCEC Buy
- Analyst Count
- ARVN 13
- CCEC 2
- Target Price
- ARVN $34.42
- CCEC $24.00
- AVG Volume (30 Days)
- ARVN 3.5M
- CCEC 12.4K
- Earning Date
- ARVN 05-06-2025
- CCEC 04-29-2025
- Dividend Yield
- ARVN N/A
- CCEC 3.14%
- EPS Growth
- ARVN N/A
- CCEC 20.78
- EPS
- ARVN N/A
- CCEC 2.60
- Revenue
- ARVN $263,399,999.00
- CCEC $369,413,000.00
- Revenue This Year
- ARVN N/A
- CCEC $19.13
- Revenue Next Year
- ARVN $7.99
- CCEC $20.93
- P/E Ratio
- ARVN N/A
- CCEC $162.75
- Revenue Growth
- ARVN 235.54
- CCEC 2.45
- 52 Week Low
- ARVN $6.88
- CCEC $14.45
- 52 Week High
- ARVN $41.34
- CCEC $20.26
- Technical
- Relative Strength Index (RSI)
- ARVN 23.50
- CCEC N/A
- Support Level
- ARVN $8.51
- CCEC N/A
- Resistance Level
- ARVN $9.17
- CCEC N/A
- Average True Range (ATR)
- ARVN 0.55
- CCEC 0.00
- MACD
- ARVN -0.05
- CCEC 0.00
- Stochastic Oscillator
- ARVN 5.24
- CCEC 0.00
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About CCEC Capital Clean Energy Carriers Corp. Common Share
Capital Clean Energy Carriers Corp is an international shipping company. It is the leading platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.